- Home
- TOPP vs COEP Comparison
TOPP vs COEP Comparison
Compare TOPP & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPP
- COEP
- Stock Information
- Founded
- TOPP 2014
- COEP 2017
- Country
- TOPP United States
- COEP United States
- Employees
- TOPP N/A
- COEP N/A
- Industry
- TOPP
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TOPP
- COEP Health Care
- Exchange
- TOPP NYSE
- COEP Nasdaq
- Market Cap
- TOPP 26.6M
- COEP 27.4M
- IPO Year
- TOPP 2025
- COEP N/A
- Fundamental
- Price
- TOPP $1.74
- COEP $9.47
- Analyst Decision
- TOPP
- COEP
- Analyst Count
- TOPP 0
- COEP 0
- Target Price
- TOPP N/A
- COEP N/A
- AVG Volume (30 Days)
- TOPP 6.7K
- COEP 37.4K
- Earning Date
- TOPP 08-11-2025
- COEP 08-15-2025
- Dividend Yield
- TOPP N/A
- COEP N/A
- EPS Growth
- TOPP N/A
- COEP N/A
- EPS
- TOPP N/A
- COEP N/A
- Revenue
- TOPP $16,117,227.00
- COEP $62,874.00
- Revenue This Year
- TOPP N/A
- COEP N/A
- Revenue Next Year
- TOPP N/A
- COEP N/A
- P/E Ratio
- TOPP N/A
- COEP N/A
- Revenue Growth
- TOPP 0.44
- COEP N/A
- 52 Week Low
- TOPP $0.97
- COEP $2.31
- 52 Week High
- TOPP $4.50
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- TOPP N/A
- COEP 62.24
- Support Level
- TOPP N/A
- COEP $7.25
- Resistance Level
- TOPP N/A
- COEP $9.90
- Average True Range (ATR)
- TOPP 0.00
- COEP 0.63
- MACD
- TOPP 0.00
- COEP 0.26
- Stochastic Oscillator
- TOPP 0.00
- COEP 85.62
About TOPP TOPPOINT HOLDINGS INC
Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.